About

Science

Pipeline

Investor Information

Contact Us

Investor Information

Investor Information

Press Releases

Sep 30, 2020 7:00 AM EDT Can-Fite Selected to Deliver Late-Breaking Oral Presentation on Namodenoson’s Treatment of NASH at American Association for the Study of Liver Diseases Conference
Sep 22, 2020 7:00 AM EDT Can-Fite to Participate in Two BioPharma Partnering Conferences
Sep 8, 2020 7:00 AM EDT Can-Fite to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
Aug 31, 2020 7:00 AM EDT FDA Clears Can-Fite to Commence Phase II COVID-19 Study
Aug 27, 2020 7:00 AM EDT Can-Fite Reports Second Quarter 2020 Financial Results & Provides Clinical Update
Aug 26, 2020 7:00 AM EDT Can-Fite to Present at The LD Micro 500 Virtual Conference on September 1, 2020
Aug 25, 2020 8:09 AM EDT Can-Fite Receives Notification of Patent Grant from European Patent Office for Namodenoson in the Treatment of NASH
Aug 20, 2020 7:00 AM EDT Can-Fite to Conduct Investor Call to Review Q2 Results and Provide Business Update on Thursday, August 27, 2020 at 4:15 p.m. ET
Jul 27, 2020 7:00 AM EDT Can-Fite Submits Investigational New Drug Application to U.S. FDA for COVID-19 Phase II Study
Jul 20, 2020 7:00 AM EDT Can-Fite Completes Development of an Assay to Identify Clinically Active Cannabis Derived Compounds

Show All